SYRE
Spyre Therapeutics Inc.
$69.67
+$0.43(+0.62%)
52
Overall
60
Value
75
Tech
23
Quality
Market Cap
$1.65B
Volume
601.09K
52W Range
$12.29 - $75.00
Target Price
$90.13
EPS Estimates Overview
| Current Quarter | $-0.66 | Next Quarter | $-0.7 |
| Current Year | $-2.8 | Next Year | $-2.88 |
| QoQ Growth | -6.1% | YoY Growth | -2.9% |
| 3Y EPS CAGR | +56.9% | Target Price | $90.13 |
| Consensus | Buy | Upside | +29.4% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SYRE | $69.67 | +0.6% | 601.09K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |